Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Nantkwest Inc CS (NK)

Nantkwest Inc CS (NK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,552,620
  • Shares Outstanding, K 109,345
  • Annual Sales, $ 110 K
  • Annual Income, $ -92,380 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 2.38
  • Price/Sales 27,858.35
  • Price/Cash Flow N/A
  • Price/Book 30.17
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.39
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 03/24/21
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate -0.18
  • Number of Estimates 1
  • High Estimate -0.18
  • Low Estimate -0.18
  • Prior Year -0.16
  • Growth Rate Est. (year over year) -12.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
23.15 +40.35%
on 03/05/21
45.42 -28.47%
on 02/22/21
+4.43 (+15.79%)
since 02/09/21
3-Month
10.00 +224.90%
on 12/10/20
45.42 -28.47%
on 02/22/21
+22.22 (+216.36%)
since 12/09/20
52-Week
2.52 +1,189.29%
on 04/03/20
45.42 -28.47%
on 02/22/21
+28.09 (+638.41%)
since 03/09/20

Most Recent Stories

More News
LBB Specialties and Imerys Form Specialty Distribution Partnership in North America

NORWALK, Conn. , Sept. 15, 2025 /PRNewswire/ -- LBB Specialties (LBBS), a leader in specialty chemicals and ingredient distribution in North America , is pleased to announce a new...

IMYSY : 5.6500 (+2.73%)
NK : 32.49 (+14.89%)
LBB Specialties and Imerys Form Specialty Distribution Partnership in North America

NORWALK, Conn. , Sept. 15, 2025 /CNW/ -- LBB Specialties (LBBS), a leader in specialty chemicals and ingredient distribution in North America , is pleased to announce a new partnership...

IMYSY : 5.6500 (+2.73%)
NK : 32.49 (+14.89%)
Lifshitz Law Firm, P.C. Announces Investigation of CATM, FFG, NK, and VIE

NEW YORK, NY / ACCESSWIRE / February 14, 2021 /Lifshitz Law Firm, P.C.: Cardtronics PLC (NASDAQ:CATM) Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection...

VIE : 53.01 (unch)
FFG : 60.99 (+0.03%)
CATM : 39.01 (+0.08%)
NK : 32.49 (+14.89%)
INVESTIGATION ALERT: Halper Sadeh LLP Investigates PRGX, RP, NK, CGIX; Shareholders Are Encouraged to Contact the Firm

INVESTIGATION ALERT: Halper Sadeh LLP Investigates PRGX, RP, NK, CGIX; Shareholders Are Encouraged to Contact the Firm NEW YORK, NY / ACCESSWIRE / February 4, 2021 / Halper Sadeh LLP, a global investor...

PRGX : 7.71 (+0.13%)
CGIX : 4.61 (-2.33%)
NK : 32.49 (+14.89%)
RP : 88.72 (+0.08%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

NantKwest, Inc. is a clinical-stage immunotherapy company. The Company's product candidates include aNK, haNK and taNK for the treatment of cancers, infectious and inflammatory diseases. It is focused on harnessing the power of the innate immune system by using the natural killer cell. NantKwest, Inc....

See More

Key Turning Points

3rd Resistance Point 37.26
2nd Resistance Point 35.20
1st Resistance Point 33.85
Last Price 32.49
1st Support Level 30.44
2nd Support Level 28.38
3rd Support Level 27.03

See More

52-Week High 45.42
Last Price 32.49
Fibonacci 61.8% 29.03
Fibonacci 50% 23.97
Fibonacci 38.2% 18.91
52-Week Low 2.52

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar